Roselle 630.529.3400 Email Us M-F 9-5pm
Sat Closed | Sun Closed
Deerfield 847.419.9898 Email Us M-Tu 9:30-6:30pm
Wed 10-2pm Th-F 9:30-6:30pm
Sat 10-2pm | Sun Closed

Mark Drugs’s NasoNeb System

The NasoNeb Nasal Nebulizer mist propellant system is the fast convenient solution for complete drug delivery coating to the nasal and paranasal sinus cavities.

The NasoNeb Nasal Nebulizer is the only low volume, high concentration delivery system available backed by peer-reviewed scientific data.

  • Unlike previous delivery devices adapted from pulmonary nebulizers that generate small particles targeting the lungs, the NasoNeb System delivers large particles that are readily filtered by the nose to ensure a large percentage of medication is delivered to the target organ and that no drug is delivered to the lungs. These particles are delivered via a positive pressure airstream that coats the whole sino-nasal cavity with the medication.1,2
  • Examples of drug classes available for use in the NasoNeb device, (alone or in combination).
  • Antibiotics
  • Antifungals
  • Anti-Viral
  • Steroids
  • Anti-Inflammatory
  • Anti-Histamine
  • Mucolytic
  • Decongestant
  • People who may benefit from topical pharmaceutical therapy delivered by the NasoNeb Nasal Nebulizer include but are not limited to the following:
  • Post-operative sinus surgery patients with recurrent nasal polyps
  • Post-sinus surgery patients with chronic nasal crusting and infection
  • Patients with bacterial or fungal infections who are not candidates for sinus surgery
  • Patients with anosmia and other rhinologic conditions
  • Patients suffering from recalcitrant allergic rhinitis

The NasoNeb Nasal Nebulizer is the only system backed by a peer-reviewed article showing enhanced, high concentration deposition throughout the nasal and paranasal sinus cavities. Effective delivery of medication to all sinus cavities can be achieved in 2 minutes or less.

You have a choice in drug delivery systems; choose the only system that is backed by peer-reviewed science.

  1. Manes RP, Tong L, Batra PS. “Prospective evaluation of aerosol delivery by a powered nasal nebulizer in the cadaver model” Int Forum Allergy Rhinol, 2011; 1:366–371
  2. Yuri M. Gelfand, MD; Samer Fakhri, MD; Amber Luong, MD, PhD; Seth J. Isaacs, MD & Martin J. Citardi, MD: “A Comparative Study of the Distribution of Normal Saline Delivered by Large Particle Nebulizer vs. Large Volume/Low Pressure Squeeze Bottle” 56th Annual Meeting of the American Rhinologic Society, September 25, 2010, page 38

To link to the MedInvent Nasal Nebulizer website, click here:

Mark Drugs Pharmacy